Dupont Capital Management Corp Crinetics Pharmaceuticals, Inc. Transaction History

Dupont Capital Management Corp

  • $1.19 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 26, 2022
BUY
$16.49 - $27.64 $37,877 - $63,489
2,297 Added 36.28%
8,629 $161,000
Q1 2022

Apr 27, 2022
SELL
$17.15 - $28.31 $9,621 - $15,881
-561 Reduced 8.14%
6,332 $139,000
Q4 2021

Jan 31, 2022
BUY
$19.35 - $28.41 $133,379 - $195,830
6,893 New
6,893 $196,000

Others Institutions Holding CRNX

# of Institutions
220
Shares Held
75.8M
Call Options Held
631K
Put Options Held
749K
View Full List

About Crinetics Pharmaceuticals, Inc.

CRNX Quotes by TradingView
  • Ticker CRNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,752,800
  • Market Cap $2.41B
  • Description
  • Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...
More about CRNX
Track This Portfolio

Track Dupont Capital Management Corp Portfolio

Follow Dupont Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Dupont Capital Management Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email